Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LENZ Therapeutics

休市中 12-20 16:00:00 EST

32.63

+2.35

+7.76%

盘后32.63

+0.000.00%

16:20 EST

最高33.84	最低29.17	成交量76.07万
今开29.75	昨收30.28	日振幅15.42%
总市值8.97亿	流通市值3.45亿	总股本2,750万
成交额2,478万	换手率7.20%	流通股本1,056万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":32.63,"timestamp":1734728400000,"preClose":30.28,"halted":0,"volume":760727,"hourTrading":{"tag":"盘后","latestPrice":32.63,"preClose":32.63,"latestTime":"16:20 EST","volume":33347,"amount":1088112.655,"timestamp":1734729600748},"delay":0,"floatShares":10564753,"shares":27500892,"eps":-2.688476,"marketStatus":"休市中","marketStatusCode":7,"change":2.35,"latestTime":"12-20 16:00:00 EST","open":29.75,"high":33.84,"low":29.17,"amount":24783097.333225,"amplitude":0.154227,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.688476,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1624593600000,"adjPreClose":30.28,"preHourTrading":{"tag":"盘前","latestPrice":30.04,"preClose":30.28,"latestTime":"09:29 EST","volume":457,"amount":13895.03473,"timestamp":1734704999999},"postHourTrading":{"tag":"盘后","latestPrice":32.63,"preClose":32.63,"latestTime":"16:20 EST","volume":33347,"amount":1088112.655,"timestamp":1734729600748},"volumeRatio":4.7876202245176245},"requestUrl":"/m/hq/s/LENZ/tweets","defaultTab":"tweets","newsList":[{"id":"2493983474","title":"美国OTC市场Finch Therapeutics Group, Inc.盘中异动 临近收盘股价大涨5.77%报11.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493983474","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493983474?lang=zh_cn&edition=full","pubTime":"2024-12-21 04:59","pubTimestamp":1734728357,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日04时59分，美国OTC市场Finch Therapeutics Group, Inc.股票出现波动，股价大幅拉升5.77%。截至发稿，该股报11.00美元/股，成交量357股，换手率0.02%，振幅3.85%。美国OTC市场Finch Therapeutics Group, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。美国OTC市场Finch Therapeutics Group, Inc.公司简介：Finch Therapeutics Group Inc是一家微生物组技术公司，拥有知识产权和微生物组资产组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221045918984d00c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221045918984d00c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FNCH","BK4139","LENZ"],"gpt_icon":0},{"id":"2493479299","title":"Lyra Therapeutics, Inc.盘中异动 急速上涨6.47%报0.181美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493479299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493479299?lang=zh_cn&edition=full","pubTime":"2024-12-21 04:55","pubTimestamp":1734728130,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日04时55分，Lyra Therapeutics, Inc.股票出现波动，股价快速上涨6.47%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221045531ab87ff03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221045531ab87ff03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","LYRA"],"gpt_icon":0},{"id":"2493347525","title":"Avalo Therapeutics, Inc.盘中异动 下午盘大幅上涨6.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493347525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493347525?lang=zh_cn&edition=full","pubTime":"2024-12-21 03:52","pubTimestamp":1734724342,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日03时52分，Avalo Therapeutics, Inc.股票出现波动，股价快速上涨6.66%。Avalo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Aptose Biosciences, Inc.涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2689.53%、498.17%、129.42%，振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为173.15%、163.64%、131.00%。Avalo Therapeutics, Inc.公司简介：Avalo Therapeutics Inc 是一家临床阶段生物技术公司，专注于免疫失调的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221035222984d0038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221035222984d0038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2493472717","title":"Y-Mabs Therapeutics, Inc.盘中异动 下午盘急速下挫5.02%报8.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493472717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493472717?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:28","pubTimestamp":1734719319,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日02时28分，Y-Mabs Therapeutics, Inc.股票出现波动，股价大幅下跌5.02%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029、Abpro Holdings, Inc涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2614.54%、484.50%、118.42%，振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为173.15%、163.64%、108.00%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221022839ab87c495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221022839ab87c495&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["YMAB","BK4139","LENZ"],"gpt_icon":0},{"id":"2493422219","title":"Dianthus Therapeutics, Inc.盘中异动 下午盘股价大涨5.08%报24.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493422219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493422219?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:02","pubTimestamp":1734717726,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日02时02分，Dianthus Therapeutics, Inc.股票出现异动，股价快速拉升5.08%。截至发稿，该股报24.21美元/股，成交量19.0471万股，换手率0.64%，振幅7.16%。Dianthus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Dianthus Therapeutics, Inc.公司简介：Dianthus Therapeutics Inc 是一家临床阶段生物技术公司，致力于设计和提供新型单克隆抗体，优化其选择性和效力并使其优于现有的补体疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122102020695ea9f70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122102020695ea9f70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","DNTH"],"gpt_icon":0},{"id":"2493424202","title":"Elicio Therapeutics, Inc.盘中异动 急速跳水5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493424202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493424202?lang=zh_cn&edition=full","pubTime":"2024-12-21 01:49","pubTimestamp":1734716956,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日01时49分，Elicio Therapeutics, Inc.股票出现异动，股价大幅跳水5.81%。Elicio Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Elicio Therapeutics, Inc.公司简介：Elicio Therapeutics Inc 是一家临床阶段的生物技术公司，致力于为治疗选择有限且结果不佳的患者开发癌症免疫疗法。Elicio 正在为一系列侵袭性癌症设计靶向淋巴结的 AMPlifiers、免疫调节剂、佐剂和疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122101491695ea9f4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122101491695ea9f4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ELTX","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2493424226","title":"Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)股价重挫12.38% 市值跌11.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493424226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493424226?lang=zh_cn&edition=full","pubTime":"2024-12-21 01:47","pubTimestamp":1734716822,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日01时47分，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 股票出现异动，股价快速下挫12.38%。Cero Therapeutics Holdings Inc C/Wts 13/02/2029 股票所在的生物技术行业中，整体涨幅为0.83%。Cero Therapeutics Holdings Inc C/Wts 13/02/2029 公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221014702a1fe7904&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221014702a1fe7904&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CEROW","BK4139","LENZ"],"gpt_icon":0},{"id":"2493421329","title":"Rapport Therapeutics, Inc.盘中异动 快速拉升5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493421329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493421329?lang=zh_cn&edition=full","pubTime":"2024-12-21 01:15","pubTimestamp":1734714929,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日01时15分，Rapport Therapeutics, Inc.股票出现异动，股价大幅上涨5.54%。Rapport Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Rapport Therapeutics, Inc.公司简介：Rapport Therapeutics Inc 是一家临床阶段的生物制药公司，专注于为中枢神经系统疾病患者发现和开发转化性小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221011529ab87a95b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221011529ab87a95b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RAPP","BK4007"],"gpt_icon":0},{"id":"2493472279","title":"Trevi Therapeutics, Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493472279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493472279?lang=zh_cn&edition=full","pubTime":"2024-12-21 01:08","pubTimestamp":1734714520,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日01时08分，Trevi Therapeutics, Inc.股票出现异动，股价急速拉升5.06%。Trevi Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。Trevi Therapeutics, Inc.公司简介：Trevi Therapeutics Inc 是一家临床阶段的生物制药公司，专注于研究疗法 Haduvio的开发和商业化，用于治疗患有特发性肺纤维化或 IPF 的成人慢性咳嗽和其他慢性咳嗽适应症，以及用于 结节性痒疹的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221010840a1fe69fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221010840a1fe69fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TRVI","BK4139","BK4007"],"gpt_icon":0},{"id":"2493421803","title":"Inhibikase Therapeutics, Inc.盘中异动 急速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493421803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493421803?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:59","pubTimestamp":1734713941,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时59分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅拉升5.06%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005901ab87a308&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005901ab87a308&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2493429863","title":"Silence Therapeutics Plc盘中异动 临近午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493429863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493429863?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:54","pubTimestamp":1734713681,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时54分，Silence Therapeutics Plc股票出现波动，股价急速拉升5.05%。截至发稿，该股报6.66美元/股，成交量18.2524万股，换手率0.39%，振幅7.57%。Silence Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.35%。Silence Therapeutics Plc公司简介：Silence Therapeutics PLC是一家专注于发现和开发含有短干扰核糖核酸的新分子的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005441a1fe63fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005441a1fe63fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLN","BK4139","LENZ"],"gpt_icon":0},{"id":"2493426054","title":"Kyverna Therapeutics, Inc.盘中异动 快速上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493426054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493426054?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:49","pubTimestamp":1734713398,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时49分，Kyverna Therapeutics, Inc.股票出现异动，股价快速上涨5.17%。Kyverna Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Abpro Holdings, Inc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2535.67%、409.53%、97.89%，振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.，振幅分别为173.15%、155.76%、105.11%。Kyverna Therapeutics, Inc.公司简介：Kyverna Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221004958a1fe625b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221004958a1fe625b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYTX","LENZ","BK4139"],"gpt_icon":0},{"id":"2493051425","title":"Tango Therapeutics, Inc.盘中异动 急速拉升5.10%报3.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493051425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493051425?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:38","pubTimestamp":1734712686,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时38分，Tango Therapeutics, Inc.股票出现异动，股价急速拉升5.10%。截至发稿，该股报3.09美元/股，成交量26.6445万股，换手率0.25%，振幅9.52%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2507.94%、380.31%、94.68%，振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.，振幅分别为173.15%、155.76%、105.11%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003806984cfe76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003806984cfe76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNGX","BK4139","LENZ"],"gpt_icon":0},{"id":"2493425205","title":"Sage Therapeutics, Inc.盘中异动 急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493425205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493425205?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:37","pubTimestamp":1734712645,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时37分，Sage Therapeutics, Inc.股票出现波动，股价快速上涨5.00%。Sage Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2507.03%、379.54%、94.62%，振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.，振幅分别为173.15%、155.76%、105.11%。Sage Therapeutics, Inc.公司简介：Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122100372595ea9e91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122100372595ea9e91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SAGE"],"gpt_icon":0},{"id":"2493426217","title":"Entero Therapeutics Inc.盘中异动 临近午盘大幅下跌7.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493426217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493426217?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:35","pubTimestamp":1734712520,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时35分，Entero Therapeutics Inc.股票出现波动，股价急速下挫7.26%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2502.63%、373.59%、93.95%，振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.，振幅分别为173.15%、155.76%、105.11%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003520ab8799a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003520ab8799a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENTO","LENZ","BK4139"],"gpt_icon":0},{"id":"2493425770","title":"Spyre Therapeutics, Inc.盘中异动 大幅上涨5.06%报24.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493425770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493425770?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:30","pubTimestamp":1734712242,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时30分，Spyre Therapeutics, Inc.股票出现波动，股价大幅上涨5.06%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Spyre Therapeutics, Inc.公司简介：Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程，合理的治疗组合和精确的医学方法来为患者选择，创造下一代炎症性肠病产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003042a1fe5b0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221003042a1fe5b0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SYRE"],"gpt_icon":0},{"id":"2493429662","title":"Leap Therapeutics, Inc.盘中异动 早盘急速拉升5.04%报2.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493429662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493429662?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:28","pubTimestamp":1734712101,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时28分，Leap Therapeutics, Inc.股票出现异动，股价大幅拉升5.04%。Leap Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Leap Therapeutics, Inc.公司简介：Leap Therapeutics 公司致力于开发治疗癌症的靶向抗体疗法，专注于抑制肿瘤促进途径，靶向癌症特异性细胞表面分子以及激活免疫系统对抗癌细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002822ab879710&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002822ab879710&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4505","LENZ","BK4139","LPTX"],"gpt_icon":0},{"id":"2493842565","title":"Alterity Therapeutics Limited盘中异动 早盘股价大涨7.26%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493842565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493842565?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:20","pubTimestamp":1734711640,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时20分，Alterity Therapeutics Limited股票出现波动，股价急速拉升7.26%。截至发稿，该股报2.25美元/股，成交量1.101万股，换手率0.13%，振幅6.43%。Alterity Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Aptose Biosciences, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2415.87%、302.69%、89.11%，振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Aptose Biosciences, Inc.，振幅分别为173.15%、147.88%、105.11%。Alterity Therapeutics Limited公司简介：Alterity Therapeutics Ltd 活跃在医疗保健领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002040984cfe3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002040984cfe3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PRNAF","ATHE","BK4139"],"gpt_icon":0},{"id":"2493842344","title":"Neurosense Therapeutics Ltd.盘中异动 急速上涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493842344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493842344?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:10","pubTimestamp":1734711011,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时10分，Neurosense Therapeutics Ltd.股票出现异动，股价急速上涨6.25%。截至发稿，该股报1.36美元/股，成交量56.75万股，换手率2.45%，振幅9.38%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.10%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221001011a1fe52ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221001011a1fe52ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRSN","LENZ"],"gpt_icon":0},{"id":"2493009425","title":"Vera Therapeutics, Inc.盘中异动 股价大涨5.15%报44.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493009425","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493009425?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:08","pubTimestamp":1734710907,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时08分，Vera Therapeutics, Inc.股票出现异动，股价急速拉升5.15%。截至发稿，该股报44.22美元/股，成交量37.0749万股，换手率0.59%，振幅7.16%。Vera Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Vera Therapeutics, Inc.公司简介：Vera Therapeutics Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221000827984cfe14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221000827984cfe14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERA","BK4585","BK4139","BK4539","BK4588","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.graphitebio.com","stockEarnings":[{"period":"1week","weight":0.0536},{"period":"1month","weight":-0.0377},{"period":"3month","weight":0.4573},{"period":"6month","weight":0.7724},{"period":"1year","weight":0.9836},{"period":"ytd","weight":0.7792}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"LENZ Therapeutics, Inc.于2017年6月1日加拿大安大略省注册成立，并于2019年10月在特拉华州重新注册。他们是一家临床阶段的下一代基因编辑公司，利用高效靶向基因整合开发新型疗法有可能治愈范围广泛的严重和危及生命的疾病。他们正在开创一种精确的基因编辑方法，以实现医学上最难以实现的目标之一：精确“找到并替换”基因组中的任何基因。他们的下一代基因编辑平台使他们能够精确地纠正突变，用正常基因替换整个致病基因，或将新基因插入预定的安全位置。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.187611},{"month":2,"riseRate":0.666667,"avgChangeRate":0.15153},{"month":3,"riseRate":0,"avgChangeRate":-0.19103},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.06634},{"month":5,"riseRate":0,"avgChangeRate":-0.187229},{"month":6,"riseRate":0.666667,"avgChangeRate":0.07217},{"month":7,"riseRate":0.5,"avgChangeRate":0.062427},{"month":8,"riseRate":0.25,"avgChangeRate":-0.053734},{"month":9,"riseRate":0.5,"avgChangeRate":-0.017856},{"month":10,"riseRate":0.75,"avgChangeRate":0.006056},{"month":11,"riseRate":0.5,"avgChangeRate":-0.013543},{"month":12,"riseRate":0.5,"avgChangeRate":0.097329}],"exchange":"NASDAQ","name":"Therapeutics","nameEN":"Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Therapeutics,LENZ,Therapeutics股票,Therapeutics股票老虎,Therapeutics股票老虎国际,Therapeutics行情,Therapeutics股票行情,Therapeutics股价,Therapeutics股市,Therapeutics股票价格,Therapeutics股票交易,Therapeutics股票购买,Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}